Thompson Siegel & Walmsley LLC Vertex Pharmaceuticals Inc Transaction History

Thompson Siegel & Walmsley LLC

$6.71 Billion
Q3 2024

A detailed history of Thompson Siegel & Walmsley LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 7,239 shares of VRTX stock, worth $3.27 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

7,239

Previous 7,250 0.15%

Holding current value

$3.27 Million

Previous $3.4 Million 0.91%

% of portfolio

0.05%

Previous 0.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$460.0 - $505.78 $5,060 - $5,563	-11 Reduced 0.15%	7,239 $3.37 Million
Q2 2024 Aug 08, 2024	SELL	$392.81 - $485.53 $52,636 - $65,061	-134 Reduced 1.81%	7,250 $3.4 Million
Q1 2024 May 09, 2024	SELL	$407.69 - $446.08 $468,435 - $512,545	-1,149 Reduced 13.47%	7,384 $3.09 Million
Q4 2023 Feb 07, 2024	SELL	$343.0 - $410.68 $57,281 - $68,583	-167 Reduced 1.92%	8,533 $3.47 Million
Q3 2023 Nov 08, 2023	SELL	$338.18 - $362.46 $94,014 - $100,763	-278 Reduced 3.1%	8,700 $3.03 Million
Q2 2023 Aug 10, 2023	SELL	$314.42 - $351.91 $199,342 - $223,110	-634 Reduced 6.6%	8,978 $3.16 Million
Q1 2023 May 11, 2023	SELL	$283.23 - $323.1 $236,497 - $269,788	-835 Reduced 7.99%	9,612 $3.03 Million
Q4 2022 Feb 10, 2023	BUY	$285.76 - $321.48 $2.99 Million - $3.36 Million	10,447 New	10,447 $3.02 Million
Q3 2022 Oct 25, 2022	SELL	$273.83 - $305.53 $473,725 - $528,566	-1,730 Reduced 13.34%	11,236 $3.25 Million
Q2 2022 Jul 22, 2022	SELL	$234.96 - $292.55 $1.84 Million - $2.29 Million	-7,822 Reduced 37.63%	12,966 $3.65 Million
Q1 2022 Apr 26, 2022	SELL	$221.42 - $260.97 $4.71 Million - $5.55 Million	-21,274 Reduced 50.58%	20,788 $5.43 Million
Q4 2021 Feb 09, 2022	SELL	$177.01 - $223.45 $537,933 - $679,064	-3,039 Reduced 6.74%	42,062 $9.24 Million
Q3 2021 Nov 05, 2021	BUY	$181.39 - $202.99 $1.64 Million - $1.83 Million	9,039 Added 25.07%	45,101 $8.18 Million
Q2 2021 Aug 09, 2021	BUY	$187.49 - $221.1 $6.51 Million - $7.68 Million	34,742 Added 2631.97%	36,062 $7.27 Million
Q1 2021 May 07, 2021	BUY	$207.02 - $241.31 $208,262 - $242,757	1,006 Added 320.38%	1,320 $284,000
Q4 2020 Feb 08, 2021	SELL	$207.01 - $276.09 $8,280 - $11,043	-40 Reduced 11.3%	314 $74,000
Q1 2020 May 12, 2020	SELL	$199.77 - $247.81 $1,997 - $2,478	-10 Reduced 2.75%	354 $84,000
Q4 2019 Feb 07, 2020	BUY	$166.71 - $223.91 $1,667 - $2,239	10 Added 2.82%	364 $80,000
Q4 2017 Feb 09, 2018	BUY	$137.28 - $155.55 $41,184 - $46,665	300 Added 555.56%	354 $53,000
Q2 2017 Aug 09, 2017	BUY	N/A	54	54 $7,000

Others Institutions Holding VRTX

# of Institutions

1,721

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.

Account

Thompson Siegel & Walmsley LLC Vertex Pharmaceuticals Inc Transaction History